Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-04-20
2010-10-12
Saoud, Christine J (Department: 1647)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C424S130100, C424S142100, C530S350000
Reexamination Certificate
active
07811990
ABSTRACT:
Described herein are methods and compositions for the treatment of spinal disorders mediated by nucleus pulposus. The compositions can include a soluble cytokine receptor and/or a TNF-α blocking antibody.
REFERENCES:
patent: 4666897 (1987-05-01), Golub et al.
patent: 4925833 (1990-05-01), McNamara et al.
patent: 5304633 (1994-04-01), Tomita et al.
patent: 5565272 (1996-10-01), Masui et al.
patent: 5565425 (1996-10-01), Yamamoto et al.
patent: 5574022 (1996-11-01), Roberts et al.
patent: 5602157 (1997-02-01), Christensen, IV
patent: 5605690 (1997-02-01), Jacobs et al.
patent: 5650396 (1997-07-01), Carlino et al.
patent: 5656272 (1997-08-01), Le et al.
patent: 5672347 (1997-09-01), Aggarwal et al.
patent: 5686428 (1997-11-01), Eriksson
patent: 5698195 (1997-12-01), Le
patent: 5703092 (1997-12-01), Xue et al.
patent: 5756482 (1998-05-01), Roberts et al.
patent: 5763446 (1998-06-01), Sadun et al.
patent: 5795967 (1998-08-01), Aggarwal et al.
patent: 5919452 (1999-07-01), Le
patent: 5962481 (1999-10-01), Levin et al.
patent: 6001828 (1999-12-01), Andrulis, Jr. et al.
patent: 6015557 (2000-01-01), Tobinick et al.
patent: 6177077 (2001-01-01), Tobinick
patent: 6180355 (2001-01-01), Alexander et al.
patent: 6277966 (2001-08-01), Kayane et al.
patent: 6277969 (2001-08-01), Le
patent: 6284471 (2001-09-01), Le
patent: 6319910 (2001-11-01), Amin et al.
patent: 6379666 (2002-04-01), Tobinick
patent: 6406867 (2002-06-01), Yu et al.
patent: 6419934 (2002-07-01), Tobinick
patent: 6419944 (2002-07-01), Tobinick
patent: 6423321 (2002-07-01), Tobinick
patent: 6428787 (2002-08-01), Tobinick
patent: 6471961 (2002-10-01), Tobinick
patent: 6537549 (2003-03-01), Tobinick
patent: 6623736 (2003-09-01), Tobinick
patent: 6635250 (2003-10-01), Olmarker et al.
patent: 6649589 (2003-11-01), Olmarker et al.
patent: 6790444 (2004-09-01), Le
patent: 6835823 (2004-12-01), Le
patent: 6982089 (2006-01-01), Tobinick
patent: 6991791 (2006-01-01), Le
patent: 7070775 (2006-07-01), Le
patent: 7101674 (2006-09-01), Le
patent: 7115557 (2006-10-01), Olmarker
patent: 7128907 (2006-10-01), Le
patent: 7128908 (2006-10-01), Le
patent: 7135178 (2006-11-01), Le
patent: 7135179 (2006-11-01), Le
patent: 7138118 (2006-11-01), Le
patent: 7160542 (2007-01-01), Le
patent: 7160543 (2007-01-01), Le
patent: 7160995 (2007-01-01), Le
patent: 7166284 (2007-01-01), Le
patent: 7169386 (2007-01-01), Le
patent: 7169388 (2007-01-01), Le
patent: 7179466 (2007-02-01), Le
patent: 7179893 (2007-02-01), Le
patent: 7192584 (2007-03-01), Le
patent: 7204985 (2007-04-01), Le
patent: 7214376 (2007-05-01), Le
patent: 7214658 (2007-05-01), Tobinick
patent: 7223396 (2007-05-01), Le
patent: 7226250 (2007-06-01), Gatton
patent: 7226593 (2007-06-01), Le
patent: 7227003 (2007-06-01), Le
patent: 7252823 (2007-08-01), Le
patent: 7276239 (2007-10-01), Le
patent: 7335358 (2008-02-01), Le
patent: 7374761 (2008-05-01), Le
patent: 7404955 (2008-07-01), Le
patent: 7416729 (2008-08-01), Le
patent: 7425330 (2008-09-01), Le
patent: 2001/0027175 (2001-10-01), Olmarker
patent: 2001/0053764 (2001-12-01), Sims
patent: 2001/0055594 (2001-12-01), Olmarker
patent: 2002/0131954 (2002-09-01), Tobinick
patent: 2002/0132307 (2002-09-01), Le
patent: 2002/0146419 (2002-10-01), Le
patent: 2003/0007972 (2003-01-01), Tobinick
patent: 2003/0113318 (2003-06-01), Tobinick
patent: 2003/0133935 (2003-07-01), Le
patent: 2003/0147891 (2003-08-01), Le
patent: 2003/0176332 (2003-09-01), Olmarker
patent: 2003/0180299 (2003-09-01), Le
patent: 2003/0185826 (2003-10-01), Tobinick
patent: 2003/0204066 (2003-10-01), Le
patent: 2004/0115200 (2004-06-01), Le
patent: 2005/0074454 (2005-04-01), Le
patent: 2005/0220971 (2005-10-01), Coburn
patent: 2005/0249735 (2005-11-01), Le
patent: 2005/0255104 (2005-11-01), Le
patent: 2005/0260201 (2005-11-01), Le
patent: 2006/0018907 (2006-01-01), Le
patent: 2006/0051381 (2006-03-01), Tobinick
patent: 2006/0246073 (2006-11-01), Knight
patent: 2007/0104711 (2007-05-01), Olmarker
patent: 2007/0196373 (2007-08-01), Le
patent: 2007/0196375 (2007-08-01), Tobinick
patent: 2007/0298040 (2007-12-01), Le
patent: 2008/0019964 (2008-01-01), Olmarker
patent: 2008/0025976 (2008-01-01), Le
patent: 2009/0022718 (2009-01-01), Le
patent: 4 028 487 (1992-03-01), None
patent: 4 219 626 (1993-12-01), None
patent: 07-145196 (1995-06-01), None
patent: 07-274970 (1995-10-01), None
patent: 07-309771 (1995-11-01), None
patent: 08-040925 (1996-02-01), None
patent: 08-073499 (1996-03-01), None
patent: 08-143468 (1996-06-01), None
patent: 09-165342 (1997-06-01), None
patent: 9803276-6 (1998-09-01), None
patent: 9803710-4 (1998-10-01), None
patent: 9803710-4 (2000-03-01), None
patent: 0200667-4 (2002-03-01), None
patent: WO 95/05363 (1995-02-01), None
patent: WO 97/06158 (1997-02-01), None
patent: WO 97/36871 (1997-10-01), None
patent: WO 98/05357 (1998-02-01), None
patent: WO 98/06424 (1998-02-01), None
patent: WO 98/06425 (1998-02-01), None
patent: WO 98/24766 (1998-06-01), None
patent: WO 98/34919 (1998-08-01), None
patent: WO 00/01730 (2000-01-01), None
patent: WO 00/18409 (2000-04-01), None
patent: WO 00/18909 (2000-04-01), None
patent: WO 00/22666 (2000-04-01), None
patent: WO 00/50079 (2000-08-01), None
patent: WO 00/75659 (2000-12-01), None
patent: WO 01/49321 (2001-07-01), None
patent: WO 01/87328 (2001-11-01), None
patent: WO 02/080893 (2002-10-01), None
patent: WO 03/073981 (2003-09-01), None
patent: WO 2004/032718 (2004-04-01), None
U.S. Appl. No. 09/256,388, filed Feb. 24, 1999.
U.S. Appl. No. 09/980,784, filed Jan. 8, 2002.
U.S. Appl. No. 11/788,651, filed Apr. 20, 2007.
U.S. Appl. No. 60/585,735, filed Jul. 6, 2004.
U.S. Appl. No. 60/760,236, filed Jan. 18, 2006.
U.S. Appl. No. 60/738,331, filed Nov. 18, 2005.
Amin et al., “A novel mechanism of action of tetracyclines: Effects on nitric oxide synthases,”Proc. Natl. Acad. Sci. USA, 1996, 93:14014-14019.
Aoki et al., “Local Application of Disc-Related Cytokines on Spinal Nerve Roots,”Spine, 2002, 27(15):1614-1617.
Arai et al., “Indomethacin blocks the nucleus pulposus-induced effects on nerve root function. An experimental study in dogs with assessment of nerve conduction and blood flow following experimental disc herniation,”Eur. Spine J., 2004, 13(8):691-694.
Baumgartner et al., “Constitutive and Inducible Mechanisms for Synthesis and Release of Cytokines in Immune Cell Lines,”J. Immunol., 1996, 157:4087-4093.
Bidani and Heming, “Effects of Lidocaine on Cytosolic pH Regulation and Stimulus-Induced Effector Functions in Alveolar Macrophages,”Lung, 1997, 175:349-361.
Black et al., “A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells,”Nature, 1997, 385:729-733.
Bluthé et al., “Interleukin-1 mediates behavioural but not metabolic effects of tumor necrosis factor α in mice,”Eur. J. Pharmacol., 1991, 209:281-283.
Boden et al., “Abnormal Magnetic-Resonance Scans of the Lumbar Spine in Asymptomatic Subjects. A prospective investigation,”J. Bone Joint Surg., 1990, 72A(3):403-408.
Boos et al., “1995 Volvo Award in Clinical Sciences. The Diagnostic Accuracy of Magnetic Resonance Imaging, Work Perception, and Psychosocial Factors in Identifying Symptomatic Disc Herniations,”Spine, 1995, 20(24):2613-2625.
Boos et al., “Tissue Characterization of Symptomatic and Asymptomatic Disc Herniations by Quantitative Magnetic Resonance Imaging,”J. Orthop. Res., 1997, 15:141-149.
Bourrie et al., “Enhancement of endotoxin-induced interleukin-10 production by SR 31747A, a sigma ligand,”Eur. J. Immunol., 1995, 25:2882-2887.
Brattsand and Linden, “Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies,”Aliment Pharmacol. Ther., 1996, 10(suppl 2):81-90.
Brisby et al., “Proinflammatory cytokines in cerebrospinal fluid and serum in patients with disc herniation and sciatica,”Eur. Spine J., 2002, 11:62-66.
Brisby et al., “Inflammation in disc herniation may be a response to nucleus pulposus cell cy
Olmarker Kjell
Rydevik Bjorn
Fish & Richardson P.C.
Lockard Jon M
Saoud Christine J
Sciaticon AB
LandOfFree
Soluble cytokine receptors TNF-α blocking antibodies... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Soluble cytokine receptors TNF-α blocking antibodies..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Soluble cytokine receptors TNF-α blocking antibodies... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4163545